AZTR
$0.28+0.11 (+60.59%)
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. e...
Recent News
Wall Street Set to Open Higher Monday as Investors Look Ahead to a Week of Earnings Reports
US stocks look set to open higher in Monday's trading session ahead of a raft of earnings coming out
Why Is Azitra (AZTR) Stock Soaring Today
AZTR: Azitra Soars After First Patient Dosed in FDA Fast Track Trial
Sector Update: Health Care Stocks Mixed Late Afternoon
Health care stocks were mixed late Wednesday afternoon, with the NYSE Health Care Index adding 0.1%
Sector Update: Health Care Stocks Advance Wednesday Afternoon
Health care stocks rose Wednesday afternoon with the NYSE Health Care Index adding 0.2% and the Heal